{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T21:49:54Z","timestamp":1791409794925,"version":"4.3.3"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","cysticfibrosisjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cystic Fibrosis"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.jcf.2026.09.012","type":"journal-article","created":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T20:58:51Z","timestamp":1791406731000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Long-term outcomes of adolescents\/adults with CF screen positive, inconclusive diagnosis"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1106-4424","authenticated-orcid":false,"given":"Vito","family":"Terlizzi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Pepe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Cimbalo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Fevola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Gartner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Claut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Gramegna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Sepe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Cipolli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Esposito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Caporelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Bonomi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Carreras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donatello","family":"Salvatore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Padoan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Castellani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Farrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcf.2026.09.012_bib0001","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/s41572-024-00538-6","article-title":"Cystic fibro-sis","volume":"10","author":"Mall","year":"2024","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.jcf.2026.09.012_bib0002","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.jcf.2022.09.012","article-title":"European sur-vey of newborn bloodspot screening for CF: opportunity to address challenges and improve performance","volume":"22","author":"Munck","year":"2023","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2026.09.012_bib0003","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1016\/j.jpeds.2016.09.065","article-title":"Diagnosis of cystic fibrosis in screened populations","volume":"181","author":"Farrell","year":"2017","journal-title":"J Pediatr"},{"key":"10.1016\/j.jcf.2026.09.012_bib0004","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.jcf.2015.01.001","article-title":"Cystic Fibrosis Screen Positive, Inconclu-sive diagnosis (CFSPID): a new designation and management recommendations for in-fants with an inconclusive diagnosis following newborn screening","volume":"14","author":"Munck","year":"2015","journal-title":"J Cyst Fibros"},{"issue":"6 Suppl","key":"10.1016\/j.jcf.2026.09.012_bib0005","doi-asserted-by":"crossref","first-page":"S106","DOI":"10.1016\/j.jpeds.2009.09.003","article-title":"Cystic Fibrosis Foundation practice guidelines for the management of infants with cystic fibrosis transmembrane conductance regulator-related metabolic syndrome during the first two years of life and beyond","volume":"155","author":"Borowitz","year":"2009","journal-title":"J Pediatr"},{"key":"10.1016\/j.jcf.2026.09.012_bib0006","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1016\/j.jpeds.2016.09.066","article-title":"Cystic fibrosis transmembrane conductance regulator-related metabolic syndrome and Cystic fibrosis screen positive, inconclusive diagnosis","volume":"181","author":"Ren","year":"2017","journal-title":"J Pediatr"},{"key":"10.1016\/j.jcf.2026.09.012_bib0007","first-page":"46","article-title":"Biochemical and genetic tools to predict the progression to Cystic Fibrosis in CRMS\/CFSPID subjects: a system-atic review","volume":"51","author":"Terlizzi","year":"2024","journal-title":"Paediatr Respir Rev"},{"key":"10.1016\/j.jcf.2026.09.012_bib0008","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.jcf.2020.11.006","article-title":"Updated guidance on the management of children with cystic fibrosis transmembrane conductance regulatorrelated metabolic syn-drome\/cystic fibrosis screen positive, inconclusive diagnosis (CRMS\/CFSPID)","volume":"20","author":"Barben","year":"2021","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2026.09.012_bib0009","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1002\/ppul.24634","article-title":"Phenotype of children with inconclusive cystic fibrosis diagnosis after newborn screening","volume":"55","author":"Munck","year":"2020","journal-title":"Pedi-atr Pulmonol"},{"key":"10.1016\/j.jcf.2026.09.012_bib0010","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1007\/s00431-023-05359-5","article-title":"Risk of CFTR-related disorders and cystic fibrosis in an Italian cohort of CRMS\/CFSPID subjects in preschool and school age","volume":"183","author":"Fevola","year":"2024","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.jcf.2026.09.012_bib0011","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.jcf.2022.09.011","article-title":"ECFS Diagnostic Network Working Group. ECFS standards of care on CFTR-related disorders: updated diagnostic criteria","volume":"21","author":"Castellani","year":"2022","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2026.09.012_bib0012","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.jcf.2022.09.005","article-title":"ECFS standards of care on CFTR-related disorders: diagnostic criteria of CFTR dysfunction","volume":"21","author":"Sermet-Gaudelus","year":"2022","journal-title":"J Cyst Fibros"},{"issue":"5","key":"10.1016\/j.jcf.2026.09.012_bib0013","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.jcf.2022.04.020","article-title":"Clinical outcomes of a large cohort of individuals with the F508del\/5T;TG12 CFTR genotype","volume":"21","author":"Tosco","year":"2022","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2026.09.012_bib0014","doi-asserted-by":"crossref","first-page":"570","DOI":"10.3390\/diagnostics10080570","article-title":"Cystic fibrosis-screening positive inconclusive diagnosis: newborn screen-ing and long-term follow-up permits to early identify patients with CFTR-related dis-orders","volume":"10","author":"Castaldo","year":"2020","journal-title":"Diagnostics (Basel)"},{"key":"10.1016\/j.jcf.2026.09.012_bib0015","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1513\/AnnalsATS.202201-024OC","article-title":"Cystic fibrosis screen positive, In-conclusive diagnosis genotypes in people with Cystic fibrosis from the U.S. Patient registry","volume":"20","author":"Salinas","year":"2023","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.jcf.2026.09.012_bib0016","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s13052-020-00948-8","article-title":"Cystic fibrosis in Tuscany: evolution of newborn screening strategies over time to the present","volume":"47","author":"Botti","year":"2021","journal-title":"Ital J Pediatr"},{"key":"10.1016\/j.jcf.2026.09.012_bib0017","doi-asserted-by":"crossref","DOI":"10.1002\/ppul.27483","article-title":"Critical issues in the management of CRMS\/CFSPID children: a national real-world survey","volume":"60","author":"Terlizzi","year":"2025","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.jcf.2026.09.012_bib0018","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1007\/s00431-001-0910-8","article-title":"Negative sweat test in hypertrypsinaemic in-fants with cystic fibrosis carrying rare CFTR mutations","volume":"161","author":"Padoan","year":"2002","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.jcf.2026.09.012_bib0019","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1136\/adc.82.6.481","article-title":"Protracted neonatal hypertrypsinogenaemia, normal sweat chloride, and cystic fibrosis","volume":"82","author":"Castellani","year":"2000","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.jcf.2026.09.012_bib0020","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.jcf.2024.01.012","article-title":"ECFS standards of care on CFTR-related disorders: towards a comprehensive program for affected individuals","volume":"23","author":"De Wachter","year":"2024","journal-title":"J Cyst Fibros"},{"issue":"2","key":"10.1016\/j.jcf.2026.09.012_bib0021","first-page":"177","article-title":"A multicentre Italian study on the psychological impact of an inconclusive cystic fibrosis diagnosis after positive neonatal screening","volume":"10","author":"Tosco","year":"2023","journal-title":"Children (Basel)"},{"key":"10.1016\/j.jcf.2026.09.012_bib0022","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.jcf.2022.12.002","article-title":"High rates of anxiety detected in mothers of children with inconclusive cystic fibrosis screening results","volume":"22","author":"Ginsburg","year":"2023","journal-title":"J Cyst Fibros"},{"issue":"2","key":"10.1016\/j.jcf.2026.09.012_bib0023","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3390\/ijns5020023","article-title":"Psychological impact on parents of an inconclusive di-agnosis following newborn bloodspot screening for cystic fibrosis: a qualitative study","volume":"5","author":"Johnson","year":"2019","journal-title":"Int J Neonatal Screen"},{"key":"10.1016\/j.jcf.2026.09.012_bib0024","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S1569-1993(02)00141-8","article-title":"Evaluation of a new definition for chronic Pseudomonas aeruginosa infection in cystic fibrosis patients","volume":"2","author":"Lee","year":"2003","journal-title":"J Cyst Fi-bros"},{"issue":"7","key":"10.1016\/j.jcf.2026.09.012_bib0025","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1002\/ppul.26442","article-title":"Lung clearance index in children with cystic fibrosis previously diagnosed with CRMS\/CFSPID: a monocentric prospective experience","volume":"58","author":"Terlizzi","year":"2023","journal-title":"Pediatr Pulmonol"},{"issue":"2","key":"10.1016\/j.jcf.2026.09.012_bib0026","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02398-2021","article-title":"Normative multiple-breath washout data in school-aged children corrected for sensor error","volume":"60","author":"Kentgens","year":"2022","journal-title":"Eur Respir J"},{"issue":"2","key":"10.1016\/j.jcf.2026.09.012_bib0027","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.jcf.2023.10.008","article-title":"Elexacaftor\/Tezacaftor\/Ivacaftor therapy in cystic fibrosis children previously CFSPID: is it over-medicalization?","volume":"23","author":"Terlizzi","year":"2024","journal-title":"J Cyst Fibros"},{"issue":"7","key":"10.1016\/j.jcf.2026.09.012_bib0028","doi-asserted-by":"crossref","first-page":"6576","DOI":"10.3390\/ijms24076576","article-title":"Clinical consequences and functional impact of the rare S737F CFTR variant and its responsiveness to CFTR modulators","volume":"24","author":"Terlizzi","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.jcf.2026.09.012_bib0029","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1186\/s13023-024-03334-3","article-title":"CFTR modulators response of S737F and T465N CFTR variants on patient-derived rectal organoids","volume":"19","author":"Kleinfelder","year":"2024","journal-title":"Orphanet J Rare Dis"},{"issue":"26","key":"10.1016\/j.jcf.2026.09.012_bib0030","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.arbres.2025.12.010","article-title":"Long-term outcomes of pediatric CFSPID: a 15-year clinical and genomic study across newborn screening Cystic fibrosis units","volume":"62","author":"Morales-Tirado","year":"2026","journal-title":"Arch Bronconeumol"},{"issue":"3","key":"10.1016\/j.jcf.2026.09.012_bib0031","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.jcf.2023.04.018","article-title":"Variability of the sweat test in children with Cystic Fibrosis previous-ly CRMS\/CFSPID: a retrospective monocenter experience","volume":"22","author":"Terlizzi","year":"2023","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2026.09.012_bib0032","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpeds.2024.114287","article-title":"Diagnostic transitions of cystic fibrosis and CRMS compared after 12 years of newborn screening in California","volume":"276","author":"Sciortino","year":"2025","journal-title":"J Pediatr"},{"issue":"4","key":"10.1016\/j.jcf.2026.09.012_bib0033","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1136\/archdischild-2023-325955","article-title":"Outcome data from 15 years of cystic fibrosis newborn screening in a large UK region","volume":"109","author":"Driscoll","year":"2024","journal-title":"Arch Dis Child"},{"issue":"6","key":"10.1016\/j.jcf.2026.09.012_bib0034","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1002\/ppul.25296","article-title":"Outcomes of repeat sweat testing in cystic fibrosis newborn screen positive infants","volume":"56","author":"Bauer","year":"2021","journal-title":"Pediatr Pulmonol"},{"issue":"6","key":"10.1016\/j.jcf.2026.09.012_bib0035","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2021-051740","article-title":"Outcomes of cystic fibrosis screening-positive infants with inconclusive diagnosis at school age","volume":"148","author":"Gonska","year":"2021","journal-title":"Pediatrics"},{"key":"10.1016\/j.jcf.2026.09.012_bib0036","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1542\/peds.97.4.524","article-title":"Sweat chloride concentrations in infants homozygous or heterozygous for F508 cystic fibrosis","volume":"97","author":"Farrell","year":"1996","journal-title":"Pediatrics"},{"issue":"1","key":"10.1016\/j.jcf.2026.09.012_bib0037","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s40348-025-00194-0","article-title":"Progress of personalized medicine of cystic fibrosis in the times of efficient CFTR modulators","volume":"12","author":"T\u00fcmmler","year":"2025","journal-title":"Mol Cell Pediatr"},{"issue":"8","key":"10.1016\/j.jcf.2026.09.012_bib0038","doi-asserted-by":"crossref","first-page":"729","DOI":"10.3390\/jpm11080729","article-title":"Sweat chloride testing and nasal potential difference (NPD) are primary outcome parameters in treatment with Cystic Fibrosis transmembrane conductance regulator (CFTR) modulators","volume":"11","author":"Sermet-Gaudelus","year":"2021","journal-title":"J Pers Med"},{"issue":"6","key":"10.1016\/j.jcf.2026.09.012_bib0039","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1002\/ppul.23992","article-title":"Intra-individual biological variation in sweat chloride concentra-tions in CF, CFTR dysfunction, and healthy pediatric subjects","volume":"53","author":"Cirilli","year":"2018","journal-title":"Pediatr Pulmonol"},{"issue":"5","key":"10.1016\/j.jcf.2026.09.012_bib0040","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1002\/ppul.24721","article-title":"Trend of sweat chloride values in a cohort of patients carrying CFTR mutations of varying clinical consequence: is there a risk of increasing sweat chloride over time?","volume":"55","author":"Terlizzi","year":"2020","journal-title":"Pediatr Pulmonol"},{"issue":"2","key":"10.1016\/j.jcf.2026.09.012_bib0041","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.jcf.2024.12.006","article-title":"Sweat chloride reflects CFTR function and correlates with clinical outcomes following CFTR modulator treatment","volume":"24","author":"Zemanick","year":"2025","journal-title":"J Cyst Fibros"},{"issue":"3","key":"10.1016\/j.jcf.2026.09.012_bib0042","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.3390\/ijms23031437","article-title":"Assays of CFTR function In vitro, ex vivo and In vivo","volume":"23","author":"Ramalho","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"5","key":"10.1016\/j.jcf.2026.09.012_bib0043","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.jcf.2015.01.005","article-title":"Association of sweat chloride concentration at time of diagnosis and CFTR genotype with mortality and cystic fibrosis phenotype","volume":"14","author":"McKone","year":"2015","journal-title":"J Cyst Fibros"},{"issue":"4","key":"10.1016\/j.jcf.2026.09.012_bib0044","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1053\/j.gastro.2004.07.006","article-title":"CFTR Cl- channel function in native human colon correlates with the genotype and phenotype in cystic fibrosis","volume":"127","author":"Hirtz","year":"2004","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.jcf.2026.09.012_bib0045","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jcf.2013.09.007","article-title":"Sweat chloride as a biomarker of CFTR activity: proof of concept and ivacaftor clinical trial data","volume":"13","author":"Accurso","year":"2014","journal-title":"J Cyst Fibros"},{"issue":"9370","key":"10.1016\/j.jcf.2026.09.012_bib0046","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1016\/S0140-6736(03)13368-5","article-title":"Effect of genotype on phenotype and mortality in cystic fibrosis: a retrospective cohort study","volume":"361","author":"McKone","year":"2003","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.jcf.2026.09.012_bib0047","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.jcf.2022.01.004","article-title":"Standards of care guidance for sweat testing; phase two of the ECFS quality improvement programme","volume":"21","author":"Cirilli","year":"2022","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2026.09.012_bib0048","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1164\/rccm.201901-0145OC","article-title":"Correlating cystic Fibrosis transmembrane conductance regulator function withClinical Featu-res to inform precision treatment of Cystic fibrosis","volume":"199","author":"McCague","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"10.1016\/j.jcf.2026.09.012_bib0049","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.jcf.2021.03.015","article-title":"A survey of the prevalence, management and outcome of infants with an inconclusive diagnosis following newborn bloodspot screening for cystic fibrosis (CRMS\/CFSPID) in six Italian centres","volume":"20","author":"Terlizzi","year":"2021","journal-title":"J Cyst Fibros"},{"issue":"7","key":"10.1016\/j.jcf.2026.09.012_bib0050","doi-asserted-by":"crossref","DOI":"10.1002\/ppul.71200","article-title":"Variations in the management of Canadian patients with CFTR related metabolic syndrome\/cystic fibrosis screen positive, inconclusive diagnosis (CRMS\/CFSPID)","volume":"60","author":"Chemali","year":"2025","journal-title":"Pediatr Pulmonol"},{"issue":"7","key":"10.1016\/j.jcf.2026.09.012_bib0051","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1002\/ppul.27023","article-title":"New York State Cystic Fibrosis Newborn Screening Consortium; Langfelder-Schwind E. Genetic counseling access and service delivery in New York State is variable for parents of infants with complex CFTR genotypes conferring uncertain phenotypes","volume":"59","author":"Kay","year":"2024","journal-title":"Pediatr Pulmonol"}],"container-title":["Journal of Cystic Fibrosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199326037653?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199326037653?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T20:58:58Z","timestamp":1791406738000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1569199326037653"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":51,"alternative-id":["S1569199326037653"],"URL":"https:\/\/doi.org\/10.1016\/j.jcf.2026.09.012","relation":{},"ISSN":["1569-1993"],"issn-type":[{"value":"1569-1993","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term outcomes of adolescents\/adults with CF screen positive, inconclusive diagnosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Cystic Fibrosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcf.2026.09.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}